Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

被引：0
作者：
A Tchirkov
J-L Couderc
B Périssel
C Goumy
A Regnier
N Uhrhammer
P Verrelle
M Berger
机构：
[1] Centre Jean Perrin,
[2] Service de Cytogénétique Médicale,undefined
[3] CHU – Faculté de Médecine,undefined
[4] UMR 384 INSERM,undefined
[5] Service de Médecine Interne,undefined
[6] CH,undefined
[7] Hématologie,undefined
[8] Faculté de Médecine,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 168
页数：1
相关论文
共 50 条
[21]   Novel e8a2 BCR/ABL Fusion Transcript in Case of a Myeloproliferative Neoplasm [J].
Manoj Kumar Panigrahi ;
Dushyant Kumar ;
Anurag Mehta ;
Moushumi Suryavanshi ;
Dinesh Bhurani ;
Kandarpa Kumar Saikia .
Indian Journal of Hematology and Blood Transfusion, 2017, 33 :271-272
[22]   Novel e8a2 BCR/ABL Fusion Transcript in Case of a Myeloproliferative Neoplasm [J].
Panigrahi, Manoj Kumar ;
Kumar, Dushyant ;
Mehta, Anurag ;
Suryavanshi, Moushumi ;
Bhurani, Dinesh ;
Saikia, Kandarpa Kumar .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (02) :271-272
[23]   e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants? [J].
Demehri, S ;
Paschka, P ;
Schultheis, B ;
Lange, T ;
Koizumi, T ;
Sugimoto, T ;
Branford, S ;
Lim, LC ;
Kegel, T ;
Martinelli, G ;
Hochhaus, A ;
Drucker, BJ ;
Deininger, MWN .
LEUKEMIA, 2005, 19 (04) :681-684
[24]   Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia [J].
Carella, Angelo Michele .
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) :249-251
[25]   e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease? [J].
Colla, S ;
Sammarelli, G ;
Voltolini, S ;
Crugnola, M ;
Sebastio, P ;
Giuliani, N .
HAEMATOLOGICA, 2004, 89 (05) :611-613
[26]   Poor response to imatinib therapy in chronic myeloid leukaemia expressing variant BCR-ABL transcripts [J].
Dutt, T. ;
Lucas, C. M. ;
Wang, L. ;
Clark, R. E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 :66-66
[27]   The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia [J].
Wang, LH ;
Knight, K ;
Lucas, C ;
Clark, RE .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02) :235-239
[28]   A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia [J].
Jin, Caibao ;
Zhu, Xiaojian ;
Xiao, Min ;
Liu, Songya ;
Liu, Xian ;
Liu, Jingjing ;
Xu, Xiuwen ;
Yi, Shujuan ;
Meng, Li .
ANNALS OF LABORATORY MEDICINE, 2018, 38 (02) :169-171
[29]   A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript [J].
Li, Xiaoqing ;
Yang, Jing ;
Chen, Xiangjun ;
Liu, Jun ;
Li, Hongrui ;
Zheng, Jine ;
He, Yanli ;
Chen, Zhong ;
Huang, Shiang .
CANCER GENETICS AND CYTOGENETICS, 2007, 176 (02) :166-168
[30]   Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib [J].
Tsaur, Grigory ;
Ivanova, Anna ;
Popov, Alexander ;
Yakovleva, Yulia ;
Riger, Tatyana ;
Plekhanova, Olga ;
Ivanets, Yulia ;
Misyurin, Andrey ;
Suchkova, Marina ;
Shorikov, Egor ;
Saveliev, Leonid ;
Fechina, Larisa .
BLOOD, 2010, 116 (21) :1402-1402
12345